Completed
Emory Angioplasty Versus Surgery Trial (EAST)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-18
N/A
Participants Needed
N/A
Research Sites
582 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare the efficacy of coronary artery bypass graft (CABG) surgery with percutaneous transluminal coronary angioplasty (PTCA) in patients with multiple vessel coronary heart disease.
CONDITIONS
Official Title
Emory Angioplasty Versus Surgery Trial (EAST)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Men and women with multivessel coronary artery disease whose symptoms were refractory to medical treatment.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here